Therefore, the dysregulation of NEAT1 can be regarded as a robust and credible adverse prognostic factor in human cancer, which will help to develop effective strategies for the diagnosis, treatment and prognosis of cancer in the future. The gene discussed is NEAT1; the disease is cancer.